1. Cancer Biology

Weakly migratory metastatic breast cancer cells activate fibroblasts via microvesicle-Tg2 to facilitate dissemination and metastasis

  1. Samantha C Schwager
  2. Katherine Young
  3. Lauren A Hapach
  4. Caroline M Carlson
  5. Jenna A Mosier
  6. Tanner J McArdle
  7. Wenjun Wang
  8. Curtis Schunk
  9. Anissa L Jayathilake
  10. Madison E Bates
  11. Francois Bordeleau
  12. Marc A Antonyak
  13. Richard A Cerione
  14. Cynthia A Reinhart-King  Is a corresponding author
  1. Vanderbilt University, United States
  2. Cornell University, United States
  3. Vanderbilt University Medical Center, United States
  4. Hume-Fogg Academic High School, United States
  5. Université Laval, Canada
https://doi.org/10.7554/eLife.74433
Share this article
Cite this article
  1. Samantha C Schwager
  2. Katherine Young
  3. Lauren A Hapach
  4. Caroline M Carlson
  5. Jenna A Mosier
  6. Tanner J McArdle
  7. Wenjun Wang
  8. Curtis Schunk
  9. Anissa L Jayathilake
  10. Madison E Bates
  11. Francois Bordeleau
  12. Marc A Antonyak
  13. Richard A Cerione
  14. Cynthia A Reinhart-King
(2022)
Weakly migratory metastatic breast cancer cells activate fibroblasts via microvesicle-Tg2 to facilitate dissemination and metastasis
eLife 11:e74433.
https://doi.org/10.7554/eLife.74433
  2. Download BibTeX
  3. Download .RIS

Abstract

Cancer cell migration is highly heterogeneous, and the migratory capability of cancer cells is thought to be an indicator of metastatic potential. It is becoming clear that a cancer cell does not have to be inherently migratory to metastasize, with weakly migratory cancer cells often found to be highly metastatic. However, the mechanism through which weakly migratory cells escape from the primary tumor remains unclear. Here, utilizing phenotypically sorted highly and weakly migratory human breast cancer cells, we demonstrate that weakly migratory metastatic cells disseminate from the primary tumor via communication with stromal cells. While highly migratory cells are capable of single cell migration, weakly migratory cells rely on cell-cell signaling with fibroblasts to escape the primary tumor. Weakly migratory cells release microvesicles rich in tissue transglutaminase 2 (Tg2) which activate murine fibroblasts and lead weakly migratory cancer cell migration in vitro. These microvesicles also induce tumor stiffening and fibroblast activation in vivo and enhance the metastasis of weakly migratory cells. Our results identify microvesicles and Tg2 as potential therapeutic targets for metastasis and reveal a novel aspect of the metastatic cascade in which weakly migratory cells release microvesicles which activate fibroblasts to enhance cancer cell dissemination.

Data availability

Source data is included in supporting files. All supporting data sheets contain the figures in the file name and the figure panel in the excel tab.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Samantha C Schwager

    Department of Biomedical Engineering, Vanderbilt University, Nashville, United States
    Competing interests
    The authors declare that no competing interests exist.

  2. Katherine Young

    Department of Biomedical Engineering, Vanderbilt University, Nashville, United States
    Competing interests
    The authors declare that no competing interests exist.

  3. Lauren A Hapach

    Department of Biomedical Engineering, Cornell University, Ithaca, United States
    Competing interests
    The authors declare that no competing interests exist.

  4. Caroline M Carlson

    Department of Biomedical Engineering, Vanderbilt University, Nashville, United States
    Competing interests
    The authors declare that no competing interests exist.

  5. Jenna A Mosier

    Department of Biomedical Engineering, Vanderbilt University, Nashville, United States
    Competing interests
    The authors declare that no competing interests exist.

  6. Tanner J McArdle

    Vanderbilt University Medical Center, Nashville, United States
    Competing interests
    The authors declare that no competing interests exist.

  7. Wenjun Wang

    Department of Biomedical Engineering, Vanderbilt University, Nashville, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0907-6282

  8. Curtis Schunk

    Department of Biomedical Engineering, Vanderbilt University, Nashville, United States
    Competing interests
    The authors declare that no competing interests exist.

  9. Anissa L Jayathilake

    Hume-Fogg Academic High School, Nashville, United States
    Competing interests
    The authors declare that no competing interests exist.

  10. Madison E Bates

    Department of Biomedical Engineering, Vanderbilt University, Nashville, United States
    Competing interests
    The authors declare that no competing interests exist.

  11. Francois Bordeleau

    Faculty of Medicine, Université Laval, Québecc, Canada
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5114-1757

  12. Marc A Antonyak

    Department of Biomedical Science, Cornell University, Ithaca, United States
    Competing interests
    The authors declare that no competing interests exist.

  13. Richard A Cerione

    Department of Biomedical Science, Cornell University, Ithaca, United States
    Competing interests
    The authors declare that no competing interests exist.

  14. Cynthia A Reinhart-King

    1Department of Biomedical Engineering, Vanderbilt University, Nashville, United States
    For correspondence
    Cynthia.Reinhart-King@vanderbilt.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6959-3914

Funding

W. M. Keck Foundation

  • Cynthia A Reinhart-King

National Institute of General Medical Sciences (GM13117)

  • Cynthia A Reinhart-King

National Science Foundation (1937963)

  • Samantha C Schwager
  • Jenna A Mosier

National Science Foundation (DGE-1650441)

  • Lauren A Hapach

Cancer Research Society

  • Francois Bordeleau

National Cancer Institute (K99CA212270)

  • Francois Bordeleau

National Cancer Institute (5P30 CA68485-19)

  • Cynthia A Reinhart-King

National Institute of Diabetes and Digestive and Kidney Diseases (U24 DK059637-16)

  • Cynthia A Reinhart-King

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Experiments were performed in accordance with AAALAC guidelines and were approved by the Vanderbilt University Institutional Animal Care and Use Committee (Protocol No. M1700029-00).

Copyright

© 2022, Schwager et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,294
    views
  • 188
    downloads
  • 12
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Samantha C Schwager
  2. Katherine Young
  3. Lauren A Hapach
  4. Caroline M Carlson
  5. Jenna A Mosier
  6. Tanner J McArdle
  7. Wenjun Wang
  8. Curtis Schunk
  9. Anissa L Jayathilake
  10. Madison E Bates
  11. Francois Bordeleau
  12. Marc A Antonyak
  13. Richard A Cerione
  14. Cynthia A Reinhart-King
(2022)
Weakly migratory metastatic breast cancer cells activate fibroblasts via microvesicle-Tg2 to facilitate dissemination and metastasis
eLife 11:e74433.
https://doi.org/10.7554/eLife.74433

Share this article

https://doi.org/10.7554/eLife.74433

Categories and tags

Research organisms

Further reading

    1. Cancer Biology
    2. Cell Biology

    Changes in local mineral homeostasis facilitate the formation of benign and malignant testicular microcalcifications

    Ida Marie Boisen, Nadia Krarup Knudsen ... Martin Blomberg Jensen
    Research Article

    Testicular microcalcifications consist of hydroxyapatite and have been associated with an increased risk of testicular germ cell tumors (TGCTs) but are also found in benign cases such as loss-of-function variants in the phosphate transporter SLC34A2. Here, we show that fibroblast growth factor 23 (FGF23), a regulator of phosphate homeostasis, is expressed in testicular germ cell neoplasia in situ (GCNIS), embryonal carcinoma (EC), and human embryonic stem cells. FGF23 is not glycosylated in TGCTs and therefore cleaved into a C-terminal fragment which competitively antagonizes full-length FGF23. Here, Fgf23 knockout mice presented with marked calcifications in the epididymis, spermatogenic arrest, and focally germ cells expressing the osteoblast marker Osteocalcin (gene name: Bglap, protein name). Moreover, the frequent testicular microcalcifications in mice with no functional androgen receptor and lack of circulating gonadotropins are associated with lower Slc34a2 and higher Bglap/Slc34a1 (protein name: NPT2a) expression compared with wild-type mice. In accordance, human testicular specimens with microcalcifications also have lower SLC34A2 and a subpopulation of germ cells express phosphate transporter NPT2a, Osteocalcin, and RUNX2 highlighting aberrant local phosphate handling and expression of bone-specific proteins. Mineral disturbance in vitro using calcium or phosphate treatment induced deposition of calcium phosphate in a spermatogonial cell line and this effect was fully rescued by the mineralization inhibitor pyrophosphate. In conclusion, testicular microcalcifications arise secondary to local alterations in mineral homeostasis, which in combination with impaired Sertoli cell function and reduced levels of mineralization inhibitors due to high alkaline phosphatase activity in GCNIS and TGCTs facilitate osteogenic-like differentiation of testicular cells and deposition of hydroxyapatite.

    1. Cancer Biology

    TAK1-mediated phosphorylation of PLCE1 represses PIP2 hydrolysis to impede esophageal squamous cancer metastasis

    Qianqian Ju, Wenjing Sheng ... Cheng Sun
    Research Article

    TAK1 is a serine/threonine protein kinase that is a key regulator in a wide variety of cellular processes. However, the functions and mechanisms involved in cancer metastasis are still not well understood. Here, we found that TAK1 knockdown promoted esophageal squamous cancer carcinoma (ESCC) migration and invasion, whereas TAK1 overexpression resulted in the opposite outcome. These in vitro findings were recapitulated in vivo in a xenograft metastatic mouse model. Mechanistically, co-immunoprecipitation and mass spectrometry demonstrated that TAK1 interacted with phospholipase C epsilon 1 (PLCE1) and phosphorylated PLCE1 at serine 1060 (S1060). Functional studies revealed that phosphorylation at S1060 in PLCE1 resulted in decreased enzyme activity, leading to the repression of phosphatidylinositol 4,5-bisphosphate (PIP2) hydrolysis. As a result, the degradation products of PIP2 including diacylglycerol (DAG) and inositol IP3 were reduced, which thereby suppressed signal transduction in the axis of PKC/GSK-3β/β-Catenin. Consequently, expression of cancer metastasis-related genes was impeded by TAK1. Overall, our data indicate that TAK1 plays a negative role in ESCC metastasis, which depends on the TAK1-induced phosphorylation of PLCE1 at S1060.

    1. Cancer Biology
    2. Cell Biology

    Cell crowding activates pro-invasive mechanotransduction pathway in high-grade DCIS via TRPV4 inhibition and cell volume reduction

    Xiangning Bu, Nathanael Ashby ... Inhee Chung
    Research Article

    Cell crowding is a common microenvironmental factor influencing various disease processes, but its role in promoting cell invasiveness remains unclear. This study investigates the biomechanical changes induced by cell crowding, focusing on pro-invasive cell volume reduction in ductal carcinoma in situ (DCIS). Crowding specifically enhanced invasiveness in high-grade DCIS cells through significant volume reduction compared to hyperplasia-mimicking or normal cells. Mass spectrometry revealed that crowding selectively relocated ion channels, including TRPV4, to the plasma membrane in high-grade DCIS cells. TRPV4 inhibition triggered by crowding decreased intracellular calcium levels, reduced cell volume, and increased invasion and motility. During this process, TRPV4 membrane relocation primed the channel for later activation, compensating for calcium loss. Analyses of patient-derived breast cancer tissues confirmed that plasma membrane-associated TRPV4 is specific to high-grade DCIS and indicates the presence of a pro-invasive cell volume reduction mechanotransduction pathway. Hyperosmotic conditions and pharmacologic TRPV4 inhibition mimicked crowding-induced effects, while TRPV4 activation reversed them. Silencing TRPV4 diminished mechanotransduction in high-grade DCIS cells, reducing calcium depletion, volume reduction, and motility. This study uncovers a novel pro-invasive mechanotransduction pathway driven by cell crowding and identifies TRPV4 as a potential biomarker for predicting invasion risk in DCIS patients.